Monitoring Plasma Extracellular Vesicles in Breast Cancer Patients Under Treatment
Author Information
Author(s): Mathilde Richard, Rosalie Moreau, Mikaël Croyal, Laurent Mathiot, Jean‐Sébastien Frénel, Mario Campone, Aurélien Dupont, Julie Gavard, Gwennan André‐Grégoire, Laëtitia Guével
Primary Institution: Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes‐Angers (CRCI2NA), Inserm CNRS, Nantes Université, France
Hypothesis
Can extracellular vesicles (EVs) serve as biomarkers to predict treatment response in HR+ metastatic breast cancer patients undergoing CDK4/6 inhibitors?
Conclusion
The study found that specific lipid profiles in plasma EVs can help predict treatment responses in breast cancer patients treated with CDK4/6 inhibitors.
Supporting Evidence
- EV concentration was monitored in 44 HR+ metastatic breast cancer patients over a treatment period.
- Patients were classified into resistant, intermediate, and sensitive groups based on their treatment response.
- Distinct sphingolipid profiles were identified in EVs from resistant patients compared to sensitive ones.
- An increase in vesiclemia was associated with accelerated disease progression.
Takeaway
Doctors can look at tiny particles in the blood called extracellular vesicles to see how well breast cancer treatments are working.
Methodology
The study involved isolating EVs from plasma, measuring their concentration, and analyzing their lipid composition to correlate with treatment responses.
Potential Biases
Potential bias in patient selection and treatment history may affect the results.
Limitations
The study's findings may not be applicable to all breast cancer subtypes or treatments beyond CDK4/6 inhibitors.
Participant Demographics
Participants included 44 HR+ metastatic breast cancer patients, average age 60, and 45 healthy women, average age 54.
Statistical Information
P-Value
0.0381
Confidence Interval
not specified
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website